Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852761 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT00852761 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 34 participants.
The verdict
NCT00852761, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the efficacy and safety of two different forms of a topical steroid (clobetasol propionate) in patients with plaque-type psoriasis.
Interventions
- DRUG Olux-E Foam
- DRUG Clobex lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852761
The ClinicalTrials.gov registry entry for NCT00852761 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Olux-E Foam is the first listed.
NCT00852761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852761 about?
NCT00852761 is a clinical study titled "A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis". The purpose of the study is to determine the efficacy and safety of two different forms of a topical steroid (clobetasol propionate) in patients with plaque-type psoriasis.
What is the current status of trial NCT00852761?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2009-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00852761?
The interventions under investigation include: Olux-E Foam (DRUG), Clobex lotion (DRUG).
Who is sponsoring clinical trial NCT00852761?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.